Search results for "ffpe challenges"

Laboratory technician Tomas Zanchi shares his journey into science and why he thinks lab equipment reviews are essential

The new media panel, gene kit and advanced resins help reduce manufacturing costs while increasing the viability of gene therapies

Dr. Chris Halbrook discusses how his team are exploring new methods to combat pancreatic cancer

AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes

Informatics tools help scientists access, aggregate and analyze drug compound and clinical trial data

Established solid tumour gene panel

BASF to utilize Tropic Bio's GEiGS (Gene Editing induced Gene Silencing) technology to develop strategic crop varieties with improved resistance to disease and pests

Discover the latest tools and techniques to expand your research capacity with expert-led presentations on laboratory automation, pipetting ergonomics, biomarker detection, and more

Collaborations with the UK government and wider academic community have driven innovation to quickly meet COVID demands

Chromium Single Cell Gene Expression Flex empowers your research in remarkable new ways, enabling you to take scRNA-seq further than it’s ever gone before. This advanced chemistry provides 10x Genomics' most sensitive whole transcriptome profiling with the ultimate flexibility to meet your experimental needs every step of the way.

This transaction will expand BioIVT’s biospecimen collection network by approximately 150 sites in the US, UK, and Europe and broaden its offerings for drug and diagnostic developers

Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events

One test that can expedite NSCLC treatment selection decisions. The Oncomine Dx Target Test is the first targeted NGS-based in vitro diagnostic test for NSCLC, simultaneously delivering multiple biomarker results from one sample within four days and helping inform treatment decisions.

Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers